XML 29 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
Exit and disposal activities
12 Months Ended
Aug. 31, 2017
Restructuring and Related Activities [Abstract]  
Exit and disposal activities
Exit and disposal activities
On April 8, 2015, the Walgreens Boots Alliance Board of Directors approved a plan to implement a restructuring program (the “Cost Transformation Program”) as part of an initiative to reduce costs and increase operating efficiencies. The Cost Transformation Program implemented and built on the cost-reduction initiative previously announced by the Company on August 6, 2014 and included plans to close stores across the U.S.; reorganize corporate and field operations; drive operating efficiencies; and streamline information technology and other functions. The actions under the Cost Transformation Program focused primarily on the Retail Pharmacy USA segment, but included activities from all segments. The Company completed the Cost Transformation Program in the fourth quarter of fiscal 2017, and over the duration of the program, closed a total of 255 stores. The Company recognized cumulative pre-tax charges to its financial results in accordance with generally accepted accounting principles in the United States of America (“GAAP”) of $1.8 billion, which were primarily recorded within selling, general and administrative expenses. These charges included $743 million related to asset impairment charges, $665 million in real estate costs and $393 million in severance and other business transition and exit costs.

The Company incurred pre-tax charges of $835 million related to the Cost Transformation Program during fiscal 2017. The Company incurred pre-tax charges of $424 million related to the Cost Transformation Program during fiscal 2016. The Company incurred pre-tax charges of $542 million related to the Cost Transformation Program during fiscal 2015. Restructuring charges are recognized as the costs are incurred in accordance with GAAP.

Restructuring costs by segment are as follows (in millions):

 
Retail Pharmacy
 
 
 
 
Fiscal 2017
USA
 
International
 
Pharmaceutical Wholesale
 
Consolidated
Asset impairments
$
272

 
$
21

 
$
2

 
$
295

Real estate costs
372

 

 

 
372

Severance and other business transition and exit costs
87

 
46

 
35

 
168

Total restructuring costs
$
731

 
$
67

 
$
37

 
$
835

 
 
 
 
 
 
 
 
Fiscal 2016
 

 
 

 
 

 
 

Asset impairments
$
215

 
$
10

 
$

 
$
225

Real estate costs
89

 
1

 
1

 
91

Severance and other business transition and exit costs
70

 
18

 
20

 
108

Total restructuring costs
$
374

 
$
29

 
$
21

 
$
424

 
 
 
 
 
 
 
 
Fiscal 2015
 

 
 

 
 

 
 

Asset impairments
$
216

 
$
7

 
$

 
$
223

Real estate costs
219

 

 

 
219

Severance and other business transition and exit costs
105

 
12

 

 
117

Total restructuring costs
$
540

 
$
19

 
$

 
$
559


The changes in accrued expenses and other liabilities related to the Cost Transformation Program include the following (in millions):

 
Asset
impairments
 
Real estate
costs
 
Severance and
other business
transition and
exit costs
 
Total
Balance at August 31, 2016
$

 
$
248

 
$
27

 
$
275

Restructuring costs
295

 
372

 
168

 
835

Payments

 
(99
)
 
(119
)
 
(218
)
Other - non cash
(295
)
 

 

 
(295
)
Currency translation adjustments

 

 
3

 
3

Balance at August 31, 2017
$

 
$
521

 
$
79

 
$
600